← Open Payments lookup

MERCY OSAGHAE: Open Payments

NPI 1972169332 · KATY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,413 in 103 payments from 14 companies in 2025. Trend: 2023 $954 · 2024 $1,519 · 2025 $2,413

Food & beverage: $2,301Education: $111
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.11$384
Otsuka America Pharmaceutical, Inc.13$328
Teva Pharmaceuticals USA, Inc.12$316
ABBVIE INC.22$284
Alkermes, Inc.7$223
E.R. Squibb & Sons, L.L.C.7$217
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$210
Supernus Pharmaceuticals, Inc.7$195
Collegium Pharmaceutical, Inc.1$63
Axsome Therapeutics, Inc.3$55

Products named: REXULTI, VRAYLAR, ARISTADA, COBENFY, CAPLYTA, Qelbree, AUSTEDO XR, INGREZZA.

Industry payments across TX — which companies pay providers there.